Archive for June, 2012

Actos doubles bladder cancer risk, British study finds

A new study has confirmed that the diabetes medication Actos doubles the risk of developing bladder cancer among people who use the drug for at least two years. The Canadian study was published in the British Medical Journal (BMJ) and included more than 115,000 diabetes patients that were treated between 1988 and 2009.

Read more about Actos and bladder cancer…

Diabetes Drugs Carry Vision Risks

A popular class of drugs used to treat Type 2 diabetes may increase the risk of vision problems, a new study suggests, underlining the importance of regular eye exams for anyone with diabetes. The study is one of the largest to investigate vision loss associated with thiazolidinediones, a group of drugs that includes the well-known medications Actos and Avandia.

Read more about vision problems with diabetes drugs…

Smith & Nephew recalls hip replacement component due to side effects concerns

In June 2012, Smith & Nephew issued a worldwide recall of the metal cup component of its R3 Acetabular System hip replacements. In a press release announcing the recall, Smith & Nephew stated that patients who received an R3 hip implant had reported higher rate of problems with the device than with other hip replacements.

Read more about the Smith & Nephew hip replacement recall…

J&J Said to Pay $2.2 Billion to End Risperdal Sales Probe

Johnson & Johnson has agreed to pay as much as $2.2 billion to settle U.S. probes of the marketing of its Risperdal antipsychotic drug and other medications, two people familiar with the negotiations said. The settlement, which might be announced this week, will include a misdemeanor plea and criminal penalty of as much as $600 million. The accord also would resolve civil claims that J&J paid kickbacks to Omnicare Inc., a company that dispenses drugs at nursing homes, the people said.

Read more about the Risperdal settlements…

FDA reviews safety of innovative heart valve

Federal health officials are asking safety questions about the first artificial heart valve designed to be implanted without major surgery, ahead of a meeting this week to consider broadening its use. Last summer Edwards Lifesciences Corp. won approval for its first-of-a-kind Sapien heart valve, which can be threaded into place through one of the body’s major arteries.

Read more about the FDA’s artificial heart valve review…

FDA: Novartis Unit Recalling Introvale Birth Control Pills

The U.S. Food and Drug Administration said Wednesday that a Novartis AG unit is recalling a three-month birth-control regimen sold in the U.S. because of a packing error. The recall involves a birth-control pill called Introvale that is marketed by Sandoz. FDA said the recall, which affects 10 lots distributed between January and May 2012, was prompted by a consumer report of the inactive pills being located in the row labeled week nine.

Read more about the birth control recall…

Smith & Nephew recalls metal-on-metal hip replacement component

British medical device company Smith & Nephew has recalled the cup component of its R3 Acetabular System, a type of metal-on-metal hip replacement. The recall comes after the company received a higher than normal number of complaints from patients who received the device.

Read more about the Smith & Nephew recall…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 435 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.